Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.naturalbiocon.in | |
Market Cap | 6.91 Cr. | |
Enterprise Value(EV) | 6.67 Cr. | 2023-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.16 | Trailing Twelve Months Ending 2023-03 |
Price-Earning Ratio (PE) | 38.63 | Trailing Twelve Months Ending 2023-03 |
Industry PE | 48.58 | Trailing Twelve Months Ending 2023-03 |
Book Value / Share | 10.75 | Trailing Twelve Months Ending 2023-03 |
Price to Book Value | 0.57 | Calculated using Price: 6.08 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 1.14 Cr. | 11,372,800 Shares |
FaceValue | 10 | |
About Natural Biocon (India) Ltd. | ||
The company is engaged in the business of chemicals, natural extracts and agricultural produces. |
1 Day |
|
-2.88% |
1 Week |
|
+0.33% |
1 Month |
|
-2.09% |
3 Month |
|
+21.84% |
6 Month |
|
|
1 Year |
|
-14.00% |
2 Year |
|
-61.05% |
5 Year |
|
|
10 Year |
|
6 years | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 0.67 | 5.99 | 0.60 | -0.26 | 0.02 | 0.55 | |
Return on Capital Employed (%) | 0.95 | 8.56 | 0.98 | -0.25 | 0.03 | 0.72 | |
Return on Assets (%) | 0.66 | 5.85 | 0.57 | -0.25 | 0.02 | 0.53 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
Shh. Funds | 11 | 12 | 12 | 12 | 12 | 12 | 12 | |
Non Curr. Liab. | ||||||||
Curr. Liab. | 0 | 0 | 1 | 1 | 0 | 0 | 1 | |
Minority Int. | ||||||||
Equity & Liab. | 12 | 12 | 13 | 13 | 12 | 12 | 14 | |
Non Curr. Assets | 10 | 10 | 11 | 11 | 11 | 11 | 11 | |
Curr. Assets | 1 | 2 | 2 | 2 | 2 | 1 | 2 | |
Misc. Exp. not W/O | ||||||||
Total Assets | 12 | 12 | 13 | 13 | 12 | 12 | 14 |
Particulars | 7 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. TTM |
Net Sales | 0 | 1 | 0 | 0 | 0 | 2 | ||
Other Income | 0 | |||||||
Total Income | 0 | 1 | 0 | 0 | 0 | 2 | ||
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | -1 | |
PBIDT | 0 | 1 | 0 | 0 | 0 | 0 | ||
Interest | ||||||||
Depreciation | ||||||||
Taxation | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | ||||||||
PAT | 0 | 1 | 0 | 0 | 0 | 0 | ||
Adjusted EPS | 0 | 1 | 0 | 0 | 0 | 0 |
Particulars | 6 years | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | -1 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | ||||||
Cash Fr. Finan. | 0 | 0 | 1 | 0 | 0 | ||
Net Change | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 |
Wed, 24 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Pursuant to the Regulation 24A of the SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015 please find enclosed herewith Annual Secretarial Compliance Report issued by Rupali Modi Practicing Company Secretary for the financial year ended March 31 2023. |
Tue, 02 May 2023
Considered And Approved Audited Standalone Financial Result For The Quarter And Financial Year Ended March 31 2023. Pursuant to Regulation 30 and 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 the Board of Directors of the at their meeting held on today i.e. Tuesday May 02 2023 at the Registered Office of the Company inter-alia has considered and approved Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31 2023 along with Statement of Profit & Loss Statement of Assets & Liabilities and the Statement of Cash Flow for the financial year ended March 31 2023 in accordance with the provisions of Regulation 33 of the SEBI Listing Regulations along with the Auditors Reports thereon. |
Tue, 02 May 2023
Disclosure Under Regulation 32(1) Of SESI (Listing Obligations And Disclosure Requirements) Regulations 2015. Pursuant to SEBI circular-CIR/CFD/CMD1/162/2019 dated 24th December 2019 as amended from time to time till date regarding Format on Statement of Deviation or Variation for proceeds of public issue/rights issue preferential issue Qualified Institutions Placement (QIP) etc. in reference to Regulation 32(1) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we would like to inform that there was no Public Issue Rights Issue Preferential Issue etc during the Quarter and year ended on March 31 2023. |
Mon, 29 May 2023 |
|
|
|
|
|